I just saw Sage Therapeutics skyrocket 35.14% after Biogen's $469 million offer to acquire them. This acquisition is a strong indicator of Sage's pote...
Read
More
I just saw Sage Therapeutics skyrocket 35.14% after Biogen's $469 million offer to acquire them. This acquisition is a strong indicator of Sage's potential in the market, and I believe it could continue to perform well in the upcoming weeks.